Nvidia stock has been weighed down by factors outside its control in recent months, which is why investors could look at these two stocks to capitalize on AI adoption.

Edgewise Therapeutics recently presented long-term data from its MESA open-label extension study of investigational drug sevasemten in Becker muscular dystrophy, showing sustained stabilization of ...